Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment.
Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. · 2021
Read Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. by Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8234032.txt.
Description
Subhan and co-authors survey tumour targeting through the EPR effect in cancer treatment. Most cancer drugs lack tumour selectivity, a core weakness. Nanodrugs given by vein behave in a way that helps.
They are too large to slip through tight walls of normal vessels. They also escape quick clearance by the kidney. Tumour vessels leak, and tumours drain poorly. So nanodrugs build up in tumour tissue over time. Levels can reach several times those in plasma. The review traces progress and prospects for this route since its first report in mouse tumours.
Catalog record
| CREATOR | Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |